Advancing drug discount programs starts with collaboration and clarity
The 340B drug discount program was enacted more than 30 years ago to lower the cost of medications so providers could deliver more comprehensive services for vulnerable patients. As care delivery has evolved greatly over that time, the program has not appropriately changed to match it and is no longer effectively meeting its original intent. The program’s rapid growth and misaligned incentives have led to a muddied, complex system with …
